Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 452

1.

Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.

Zhong RK, Lane TA, Ball ED.

Exp Hematol. 2008 Apr;36(4):486-94. doi: 10.1016/j.exphem.2007.11.012. Epub 2008 Jan 30.

PMID:
18249062
2.

Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.

Kufner S, Fleischer RP, Kroell T, Schmid C, Zitzelsberger H, Salih H, de Valle F, Treder W, Schmetzer HM.

Cancer Immunol Immunother. 2005 Oct;54(10):953-70. Epub 2005 Mar 24.

PMID:
15789235
4.

Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia.

Zhong RK, Rassenti LZ, Kipps TJ, Chen J, Law P, Yu JF, Ball ED.

Biol Blood Marrow Transplant. 2002;8(10):557-68.

PMID:
12434951
5.

Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts.

Li L, Giannopoulos K, Reinhardt P, Tabarkiewicz J, Schmitt A, Greiner J, Rolinski J, Hus I, Dmoszynska A, Wiesneth M, Schmitt M.

Int J Oncol. 2006 Apr;28(4):855-61.

PMID:
16525634
6.

Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.

Kufner S, Zitzelsberger H, Kroell T, Pelka-Fleischer R, Salem A, de Valle F, Schweiger C, Nuessler V, Schmid C, Kolb HJ, Schmetzer HM.

Scand J Immunol. 2005 Jul;62(1):86-98.

7.

Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.

Barbui AM, Borleri G, Conti E, Ciocca A, Salvi A, Micò C, Introna M, Rambaldi A.

Exp Hematol. 2006 Apr;34(4):475-85.

PMID:
16569594
9.

Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity.

Jahn B, Bergmann L, Weidmann E, Brieger J, Fenchel K, Schwulera U, Hoelzer D, Mitrou PS.

Leuk Res. 1995 Feb;19(2):73-82.

PMID:
7869744
10.

Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.

Liepert A, Grabrucker C, Kremser A, Dreyssig J, Ansprenger C, Freudenreich M, Kroell T, Reibke R, Tischer J, Schweiger C, Schmid C, Kolb HJ, Schmetzer H.

Cell Immunol. 2010;265(1):23-30. doi: 10.1016/j.cellimm.2010.06.009. Epub 2010 Jun 20.

PMID:
20663492
11.

The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.

Grabrucker C, Liepert A, Dreyig J, Kremser A, Kroell T, Freudenreich M, Schmid C, Schweiger C, Tischer J, Kolb HJ, Schmetzer H.

J Immunother. 2010 Jun;33(5):523-37. doi: 10.1097/CJI.0b013e3181d87ffd.

PMID:
20463595
12.

[Induction of efficient T-cell immunity against autologous leukemia cells by dendritic cells pulsed with the leukemia cell total RNA].

Ge W, You SG, Wang YF, Li CH, Liu XF, He XP, Ma S, Qiu L.

Zhonghua Xue Ye Xue Za Zhi. 2005 Aug;26(8):461-4. Chinese.

PMID:
16383235
13.

Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.

Kremser A, Dressig J, Grabrucker C, Liepert A, Kroell T, Scholl N, Schmid C, Tischer J, Kufner S, Salih H, Kolb HJ, Schmetzer H.

J Immunother. 2010 Feb-Mar;33(2):185-99. doi: 10.1097/CJI.0b013e3181b8f4ce.

PMID:
20139775
15.

TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells.

Nieda M, Nicol A, Koezuka Y, Kikuchi A, Lapteva N, Tanaka Y, Tokunaga K, Suzuki K, Kayagaki N, Yagita H, Hirai H, Juji T.

Blood. 2001 Apr 1;97(7):2067-74.

16.

Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.

Choi BH, Kang HK, Park JS, Kim SK, Pham TN, Zhu XW, Cho D, Nam JH, Chung IJ, Kim YJ, Rhee JH, Kim HJ, Lee JJ.

J Clin Apher. 2006 Dec;21(4):233-40.

PMID:
17120232
17.
18.
19.
20.

Supplemental Content

Support Center